Stoke Therapeutics, Inc. STOK Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Stoke Therapeutics, Inc.’s reported figures.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s invested capital?
- Stoke Therapeutics, Inc. (STOK) reported invested capital of $242.64M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s invested capital changed year-over-year?
- Stoke Therapeutics, Inc.'s invested capital increased by 198.8% year-over-year, from $81.21M to $242.64M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s invested capital has grown at a 403.7% compound annual growth rate (CAGR), from -$84K to $272.39M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).